Literature DB >> 3956117

Multisystemic disease with intracranial hypertension and autoimmune cytopenia in chronic active hepatitis.

M Girino, A Riccardi, M Danova, C M Montecucco, G Ucci, E Ascari.   

Abstract

A 14-year-old girl with postinfectious chronic hepatitis developed a life threatening autoimmune multisystemic illness with arthralgias, intracranial hypertension, Coomb's positive hemolytic anemia and hemorrhagic diathesis (due to antiplatelet and antifactor X antibodies). Mannitol and immunosuppressive therapy abolished acute symptoms. During the first year of follow-up, two attempts of decreasing prednisone below 15 mg/day caused recurrence of the hemolytic anemia and appearance of low titer antinuclear antibodies, while doses above 15 mg/day caused an increase in transaminase levels. Daily prednisone dose was therefore fixed at 15 mg. The patient was well and, although signs of mild hemolysis persisted, there was no anemia. Transaminases were found greatly elevated on two occasions. An autoimmune multisystemic steroid sensitive disease was seemingly initiated by a postinfectious steroid irresponsive chronic hepatitis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3956117     DOI: 10.1007/bf02030975

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  11 in total

1.  Multisystem involvement in chronic liver disease. Studies on the incidence and pathogenesis.

Authors:  P L Golding; M Smith; R Williams
Journal:  Am J Med       Date:  1973-12       Impact factor: 4.965

2.  Lupus meningitis. Antibody to deoxyribonucleic acid (DNA) and DNA:anti-DNA complexes in cerebrospinal fluid.

Authors:  E B Keeffe; E J Bardana; R J Harbeck; B Pirofsky; R I Carr
Journal:  Ann Intern Med       Date:  1974-01       Impact factor: 25.391

3.  Hepatitis B and immune-complex disease.

Authors:  N Shusterman; W T London
Journal:  N Engl J Med       Date:  1984-01-05       Impact factor: 91.245

4.  Report of the Working Party on Acquired Inhibitors of Coagulation: studies of the "lupus" anticoagulant.

Authors:  D Green; C Hougie; F J Kazmier; K Lechner; P M Mannucci; C R Rizza; Y Sultan
Journal:  Thromb Haemost       Date:  1983-04-28       Impact factor: 5.249

Review 5.  Current problems in the diagnosis and management of chronic active hepatitis.

Authors:  A J Czaja
Journal:  Mayo Clin Proc       Date:  1981-05       Impact factor: 7.616

6.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

7.  Systemic lupus erythematosus developing in patients with primary biliary cirrhosis.

Authors:  S Hall; P H Axelsen; D E Larson; T W Bunch
Journal:  Ann Intern Med       Date:  1984-03       Impact factor: 25.391

8.  The spectrum of liver disease in systemic lupus erythematosus. Report of 33 histologically-proved cases and review of the literature.

Authors:  B A Runyon; D R LaBrecque; S Anuras
Journal:  Am J Med       Date:  1980-08       Impact factor: 4.965

9.  Hepatic disorders associated with liver-kidney microsomal antibodies.

Authors:  M G Smith; R Williams; G Walker; M Rizzetto; D Doniach
Journal:  Br Med J       Date:  1974-04-13

10.  Neurologic manifestations of systemic vasculitis. A retrospective and prospective study of the clinicopathologic features and responses to therapy in 25 patients.

Authors:  P M Moore; A S Fauci
Journal:  Am J Med       Date:  1981-10       Impact factor: 4.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.